Tobinco Donates Hydroxychloroquine To MOH To Treat COVID-19 Patients

0
Entrance Pharmaceuticals and Research Centre, a leading producer of pharmaceutical products in West Africa  and a member of the Tobinco Group of Companies has presented 1,000 courses of Hydroxychloroquine worth over GHS100,000 and 18,000 bottles of Foligrow to the Ministry of Health (MOH).
 
The  donation is aimed at supporting government in the fight against CoVID-19 in the country. Hydroxychloroquine  has been endorsed by WHO  for the treatment of COVID-19 patients.
The valuable items  were received by the Deputy Minister of Health, Dr Bernard Okoe Boye  in Accra today (Wednesday, June 17th 2020).
COVID-19 patients treated with hydroxychloroquine and azithromycin are said to recover quickly but the drugs were not available locally on a large scale, aside from the cost of drug shooting up on the international market.
Receiving the donation, Dr Okoe Boye commended the Tobinco Boss, Samuel Nana Amo Tobbin  and the Entrance Pharmaceuticals and Research Centre for supporting government with the medicine for the treatment of COVID-19 patients.
He noted that for government to succeed in the fight against COVID-19, it will take partnership such as that of the Tobinco Group, expressing hope that the partnership will last.
It will be recalled  that the Ghana Export and Import Bank (EXIM Bank) entered partnership with the Entrance Pharmaceuticals and Research Centre, to produce hydroxychloroquine and azithromycin locally for the management of COVID-19 cases.
The bank is expected to commit a $5 million facility to the company for the production of the drugs locally.

Dr Okoe Boye, therefore,  assured the Tobinco Boss that the Ministry of Health will ensure that the process of securing funding to commence the production of the drugs is expedited.

Mr Kwadwo Asare Twerefour, MD for Entrance Pharmaceuticals and Research Centre, also thanked the FDA for ensuring the drugs went through all the needed processes in due time.

He stated that the company identified the need to locally produce hydroxychloroquine and other medicines to support the government in the fight against covid-19, adding that the company is still researching and will produce the rest of the drugs that are needed to fight the disease.

Mr Asare Twerefour also expressed hope the money promised by EXIM Bank will materialise in due time so that the company can produce more of the drugs efficient enough to supply the local and  the international market.

LEAVE A REPLY

Please enter your comment!
Please enter your name here